【Kissei Pharmaceutical Co., Ltd.】 Share Buyback Completed｜July 2026

Overview of Share Buyback

Kissei Pharmaceutical Co., Ltd. completed the sale of treasury stock with restrictions on transfer to eight directors and twelve executive officers on July 23, 2026. The number of shares disposed was 19,794, with a total disposal amount of 77,988,360 yen, and a per share disposal amount of 3,940 yen. The recipients were eight directors and twelve executive officers, and this was carried out as part of the company's capital policy to strengthen executive incentives and corporate governance.

Future Outlook and Impact on Shareholders

This share buyback is considered a measure aimed at enhancing director ownership awareness and increasing corporate value. The dilutive effect on shares from the disposal is limited, and the impact on shareholder value is expected to be minimal. The company will continue to pursue sustainable growth and strengthen governance, with a focus on shareholder returns and increasing corporate value.